Next-Generation Luminescence-Based Radiation Therapy System
Legal Citation
Summary of the Inventive Concept
A real-time radiation therapy monitoring and personalized treatment system utilizing luminescence-based dosimetry and machine learning algorithms to optimize treatment efficacy and patient outcomes.
Background and Problem Solved
Conventional radiation therapy methods, as described in the original patent, often lack real-time monitoring capabilities, leading to potential under- or over-dosage. The new inventive concept addresses this limitation by integrating luminescence-based dosimetry and machine learning algorithms to provide personalized, adaptive radiation therapy plans.
Detailed Description of the Inventive Concept
The next-generation system comprises a wearable device incorporating an OSL material, which detects luminescence emissions in response to ion beam therapy and transmits corresponding data to a remote server for analysis and feedback. The system also includes a machine learning module trained on a dataset of luminescence-based radiation therapy outcomes, which predicts optimal radiation therapy plans for individual patients based on their unique characteristics and treatment goals. Furthermore, the system utilizes 3D modeling of patient tumors using luminescence-based imaging to adapt ion beam therapy plans and optimize treatment efficacy.
Novelty and Inventive Step
The new claims introduce a paradigm shift in radiation therapy by integrating real-time luminescence-based dosimetry, machine learning algorithms, and personalized treatment planning. This inventive step enables adaptive radiation therapy, which was not possible with the original patent's methodology.
Alternative Embodiments and Variations
Alternative embodiments may include implantable OSL sensors, flexible substrate-based wearable devices, or cloud-based machine learning modules. Variations may involve different luminescence materials, radiation therapy modalities, or data analysis algorithms.
Potential Commercial Applications and Market
The next-generation luminescence-based radiation therapy system has significant commercial potential in the healthcare industry, particularly in cancer treatment centers and hospitals. The system's ability to provide real-time monitoring and personalized treatment plans can improve patient outcomes, reduce treatment costs, and enhance the overall quality of care.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Radiation oncology and medical imaging technologies, focusing on ion beam therapy and luminescence-based dosimetry systems. Requires advanced knowledge of medical physics, radiation detection, and data analysis techniques
Person of Ordinary Skill (PHOSITA) Profile
A medical physicist or biomedical engineer with expertise in radiation therapy technologies, proficient in machine learning, sensor design, and radiation dose monitoring techniques
Obviousness Rationale
A PHOSITA would recognize that the PTD's integration of machine learning, real-time monitoring, and personalized treatment planning represents a predictable extension of the source patent's luminescence-based radiation therapy approach. The core technological principles of luminescence-based ion beam therapy remain consistent, with the PTD introducing incremental improvements in data analysis and treatment customization. These variations would be considered obvious improvements within the established technological framework of radiation therapy monitoring systems.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,806 |
|---|---|
| Title | Luminescence-based method for precise delivery of ion beam therapy |
| Assignee(s) | United States of America as represented by the Secretary of the Navy |